Evidence map›Paper›PMID 36090298›Full record

ArticleJID innovations : skin science from molecules to population health2022

A Phenotypic Analysis of Involucrin-Membrane-Bound Ovalbumin Mice after Adoptive Transfer of Ovalbumin-Specific CD8

Yujin Nakagawa, Gyohei Egawa, Toshiya Miyake, Saeko Nakajima, Atsushi Otsuka, Takashi Nomura, Akihiko Kitoh, Teruki Dainichi, Jun-Ichi Sakabe, Akihiko Shibaki and 3 more

Open access · goldAbstract read
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yujin NakagawaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Gyohei EgawaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Toshiya MiyakeDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Saeko NakajimaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Atsushi OtsukaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takashi NomuraDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akihiko KitohDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Teruki DainichiDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Jun-Ichi SakabeSingapore Immunology Network (SIgN) and Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.
Akihiko ShibakiShibaki Dermatology Clinic, Sapporo, Japan.
Yoshiki TokuraDepartment of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Tetsuya HondaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kenji KabashimaDepartment of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPAgency for Science, Technology and Research · SGHamamatsu University School of Medicine · JPSapporo Science Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the mechanism of autoimmunity and peripheral tolerance in the skin, several transgenic mouse strains expressing membrane-bound ovalbumin (mOVA) as an epidermal self-antigen under the control of keratinocyte-specific promotors, such as keratin 5 and keratin 14, were employed in combination with adoptive transfer of CD8

Indexed as

CTL, cytotoxic T lymphocyteDC, dendritic cellGVHD, graft-versus-host diseaseIvl, involucrinK14, keratin 14K5, keratin 5KC, keratinocyteLC, Langerhans cellLN, lymph nodemOVA, membrane-bound ovalbuminOVA, ovalbuminTg, transgenicTreg, regulatory T cell

Identifiers

PMID36090298
PMCPMC9460514
OpenAlexW4220909342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.